Art. 4 Verdrag tussen het Koninkrijk der Nederlanden en het Europees Geneesmiddelenbureau betreffende de vestiging van het Europees Geneesmiddelenbureau

1. The Agency shall have its seat in Amsterdam, the Netherlands. 2. Following consultations between the Agency and the Ministry of Foreign Affairs, the locations of the premises, in addition to the temporary and definitive headquarters of the Agency as referred to in paragraph 4 and 5 of this Article, require approval of the Ministry of Foreign Affairs, which approval will not be unreasonably withheld. 3. The host State supports the establishment of the Agency in Amsterdam by providing a suitable location in Amsterdam. 4. The definitive headquarter of the Agency will be in the building located at Domenico Scarlattilaan 6, Amsterdam, in the Zuidas district of Amsterdam. The use of the premises by the Agency shall be governed by a Lease Agreement with the Ministry of the Interior and Kingdom Relations, legally represented by the State Secretary, represented in this matter by the Director General of the Central Government Real Estate Agency (CGREA). 5. The Agency shall be temporarily hosted by the Dutch Government at the Spark building in the Sloterdijk area of Amsterdam and shall use these temporary premises in accordance with the terms and conditions separately agreed upon by the Parties. Upon request of EMA to use additional buildings or parts thereof in connection with its functions and purposes, during the period that EMA is hosted at the Spark building, the host State will ensure that the competent authorities are informed of the applicability of this Agreement to these buildings or parts thereof. 6. The Agency may display such signs, plaques, flags, and emblems on the premises as it deems appropriate. 7. The Agency shall be exclusively entitled to display its emblem on the premises of the Agency and on its means of transport.

Premises

Rechtspraak bij dit artikel